2022
DOI: 10.3389/fnmol.2022.912780
|View full text |Cite
|
Sign up to set email alerts
|

Frataxin Deficit Leads to Reduced Dynamics of Growth Cones in Dorsal Root Ganglia Neurons of Friedreich’s Ataxia YG8sR Model: A Multilinear Algebra Approach

Abstract: Computational techniques for analyzing biological images offer a great potential to enhance our knowledge of the biological processes underlying disorders of the nervous system. Friedreich’s Ataxia (FRDA) is a rare progressive neurodegenerative inherited disorder caused by the low expression of frataxin, which is a small mitochondrial protein. In FRDA cells, the lack of frataxin promotes primarily mitochondrial dysfunction, an alteration of calcium (Ca2+) homeostasis and the destabilization of the actin cytosk… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2023
2023
2023
2023

Publication Types

Select...
2

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
(1 citation statement)
references
References 51 publications
0
1
0
Order By: Relevance
“…The concentration of human frataxin protein was reduced in YG8sR in all tissues tested compared to Y47R and even more than in the YG8sR(200) for the cerebellum (i.e., 70% in the YG8sR(200) and 19% in YG8sR). Considering that YG8sR mice have a human frataxin transgene containing 250–300 GAA repeats responsible for low human frataxin expression, these mice remain a good model to study the effects of frataxin reduction [ 36 ], or to try to increase the frataxin expression by some treatments [ 37 , 38 ] or even through genetic modifications using the CRISPR-Cas9 system to delete the GAA repeat [ 19 , 20 ]. All these studies are essential to understanding the mechanism and interaction between the frataxin protein and other proteins or enzymes but at some point, it becomes essential to have a good mouse model that recreates the symptoms of Friedreich ataxia and allows for the detection of functional improvements with treatment.…”
Section: Discussionmentioning
confidence: 99%
“…The concentration of human frataxin protein was reduced in YG8sR in all tissues tested compared to Y47R and even more than in the YG8sR(200) for the cerebellum (i.e., 70% in the YG8sR(200) and 19% in YG8sR). Considering that YG8sR mice have a human frataxin transgene containing 250–300 GAA repeats responsible for low human frataxin expression, these mice remain a good model to study the effects of frataxin reduction [ 36 ], or to try to increase the frataxin expression by some treatments [ 37 , 38 ] or even through genetic modifications using the CRISPR-Cas9 system to delete the GAA repeat [ 19 , 20 ]. All these studies are essential to understanding the mechanism and interaction between the frataxin protein and other proteins or enzymes but at some point, it becomes essential to have a good mouse model that recreates the symptoms of Friedreich ataxia and allows for the detection of functional improvements with treatment.…”
Section: Discussionmentioning
confidence: 99%